14.17
전일 마감가:
$14.27
열려 있는:
$14.3
하루 거래량:
88,961
Relative Volume:
0.84
시가총액:
$409.12M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-1.05%
1개월 성능:
+6.06%
6개월 성능:
+9.25%
1년 성능:
-5.82%
Abrdn Life Sciences Investors Stock (HQL) Company Profile
HQL을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
HQL
Abrdn Life Sciences Investors
|
14.17 | 407.97M | 0 | 0 | 0 | 0.00 |
![]()
DNP
Dnp Select Income Fund Inc
|
10.00 | 3.72B | 0 | 0 | 0 | 0.00 |
![]()
UTG
Reaves Utility Income Fund
|
38.19 | 3.35B | 0 | 0 | 0 | 0.00 |
![]()
ADX
Adams Diversified Equity Fund
|
22.07 | 2.64B | 0 | 0 | 0 | 0.00 |
![]()
ETY
Eaton Vance Tax Managed Diversified Equity Income Fund
|
15.94 | 2.51B | 0 | 0 | 0 | 0.00 |
![]()
UTF
Cohen Steers Infrastructure Fund Inc
|
25.64 | 2.52B | 0 | 0 | 0 | 0.00 |
Abrdn Life Sciences Investors 주식(HQL)의 최신 뉴스
When is the best time to exit Abrdn Life Sciences InvestorsWeekly Trend Recap & Technical Pattern Based Signals - Newser
Is Abrdn Healthcare Investors reversing from oversold territoryEarnings Growth Summary & AI Driven Stock Movement Reports - Newser
Detecting price anomalies in Abrdn Life Sciences Investors with AIWeekly Trend Report & Low Drawdown Investment Strategies - Newser
Developing predictive dashboards with Abrdn Life Sciences Investors dataJuly 2025 Trade Ideas & Capital Efficient Trading Techniques - Newser
Does Abrdn Healthcare Investors show high probability of reboundWeekly Profit Recap & Safe Entry Trade Reports - Newser
Custom watchlist performance reports with Abrdn Healthcare InvestorsMarket Risk Report & Daily Growth Stock Tips - Newser
Quantitative breakdown of Abrdn Life Sciences Investors recent moveJuly 2025 Selloffs & Free AI Powered Buy and Sell Recommendations - Newser
Has Abrdn Life Sciences Investors formed a bullish divergenceMarket Sentiment Summary & Daily Profit Focused Screening - Newser
Will Abrdn Life Sciences Investors continue its uptrendEarnings Trend Report & High Accuracy Trade Alerts - Newser
Is Abrdn Life Sciences Investors meeting your algorithmic filter criteriaJuly 2025 Action & Risk Managed Trade Strategies - Newser
What to expect from Abrdn Life Sciences Investors in the next 30 daysWeekly Stock Recap & Low Risk Entry Point Guides - Newser
Is Abrdn Life Sciences Investors stock reversal real or fakeEarnings Miss & Long-Term Growth Plans - Newser
Visualizing Abrdn Healthcare Investors stock with heatmaps2025 Price Momentum & Reliable Entry Point Trade Alerts - Newser
How institutional ownership impacts Abrdn Life Sciences Investors stockEarnings Growth Report & Expert-Curated Trade Recommendations - Newser
What high frequency data says about Abrdn Healthcare Investors2025 Market Trends & Daily Growth Stock Investment Tips - Newser
Can Abrdn Life Sciences Investors hit a new high this monthPortfolio Return Report & High Accuracy Swing Entry Alerts - Newser
Tools to monitor Abrdn Life Sciences Investors recovery probability2025 Macro Impact & Low Risk Entry Point Tips - Newser
How to build a dashboard for Abrdn Life Sciences Investors stockJobs Report & Daily Momentum Trading Reports - Newser
Abrdn Life Sciences Investors stock retracement – recovery analysisWeekly Investment Recap & AI Optimized Trading Strategy Guides - Newser
Can trapped investors hope for a rebound in Abrdn Life Sciences InvestorsTrade Signal Summary & Weekly High Return Stock Forecasts - Newser
Momentum divergence signals in Abrdn Life Sciences Investors chartPortfolio Risk Summary & Daily Entry Point Alerts - Newser
Is it too late to sell Abrdn Healthcare InvestorsEarnings Risk Summary & Advanced Technical Analysis Signals - Newser
Real time breakdown of Abrdn Life Sciences Investors stock performance2025 Volume Leaders & Weekly Momentum Picks - Newser
Applying Wyckoff theory to Abrdn Healthcare Investors stockWeekly Investment Summary & Free High Accuracy Swing Entry Alerts - Newser
Is it time to cut losses on Abrdn Healthcare InvestorsJuly 2025 PostEarnings & Advanced Swing Trade Entry Plans - Newser
Needham Investment Management LLC Boosts Stake in abrdn Life Sciences Investors $HQL - MarketBeat
Raymond James Financial Inc. Purchases 74,061 Shares of abrdn Life Sciences Investors $HQL - MarketBeat
Risk adjusted return profile for Abrdn Life Sciences Investors analyzedQuarterly Profit Summary & High Accuracy Trade Signal Alerts - Newser
abrdn Life Sciences Investors (NYSE:HQL) Short Interest Update - MarketBeat
Does Abrdn Life Sciences Investors qualify in momentum factor screeningMarket Performance Summary & Fast Exit and Entry Strategy Plans - Newser
Should you hold or exit Abrdn Healthcare Investors nowJuly 2025 Spike Watch & Stepwise Trade Signal Implementation - Newser
Live market analysis of Abrdn Life Sciences InvestorsMarket Growth Summary & Capital Protection Trading Alerts - Newser
Abrdn Healthcare Investors stock prediction for this week2025 Risk Factors & Smart Money Movement Alerts - Newser
Chart overlay techniques for tracking Abrdn Healthcare Investors2025 Growth vs Value & AI Based Buy/Sell Signal Reports - Newser
Short Interest in abrdn Healthcare Investors (NYSE:HQH) Drops By 25.4% - MarketBeat
Real time social sentiment graph for Abrdn Healthcare Investors2025 Big Picture & Technical Buy Zone Confirmation - Newser
Will Abrdn Life Sciences Investors rebound enough to break evenDollar Strength & High Conviction Investment Ideas - Newser
Can momentum traders help lift Abrdn Life Sciences InvestorsJuly 2025 Final Week & Free Expert Approved Momentum Trade Ideas - Newser
Sentiment analysis tools applied to Abrdn Life Sciences InvestorsMarket Trend Summary & Daily Momentum Trading Reports - Newser
Will Abrdn Life Sciences Investors outperform the marketWeekly Profit Report & Technical Analysis for Trade Confirmation - Newser
Will earnings trigger a reversal in Abrdn Life Sciences Investors2025 Technical Patterns & High Accuracy Swing Entry Alerts - Newser
Smart tools for monitoring Abrdn Life Sciences Investors’s price actionJuly 2025 Institutional & Momentum Based Trading Ideas - Newser
Abrdn Life Sciences Investors (HQL) 재무 분석
Abrdn Life Sciences Investors (HQL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):